Dr Dmytro Bond, MD | |
5751 S Fort Apache Rd, Suite A, Las Vegas, NV 89148-5624 | |
(702) 939-0480 | |
(702) 939-0482 |
Full Name | Dr Dmytro Bond |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 5751 S Fort Apache Rd, Las Vegas, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164482147 | NPI | - | NPPES |
003102645 | Medicaid | NV | |
002018545 | Medicaid | NV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 9546 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Dmytro Bond, MD 5751 S Fort Apache Rd, Suite A, Las Vegas, NV 89148 Ph: (702) 939-0480 | Dr Dmytro Bond, MD 5751 S Fort Apache Rd, Suite A, Las Vegas, NV 89148-5624 Ph: (702) 939-0480 |
News Archive
Researchers at Thomas Jefferson University discovered that nearly half of coronary artery bypass patients are not taking statins and aspirin together when they are referred for diagnostic cardiac catheterization at least three years after their initial bypass. Their results are currently in press online in the American Journal of Cardiology.
ChemGenex Pharmaceuticals Limited and Hospira, Inc. announced today that they have entered into an exclusive agreement to license, develop and commercialize ChemGenex's product candidate omacetaxine mepesuccinate, a novel targeted cytotoxic pharmaceutical product, in Europe, the Middle East and parts of Africa (the Territory).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia.
The University of California, San Diego will lead a new Center of Expertise on Migration and Health as one of three multi-campus initiatives launched by the University of California system under the auspices of the new UC Global Health Institute.
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
› Verified 5 days ago
Randi E Lampert, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2050 Mariner Dr, Suite #150, Las Vegas, NV 89128 Phone: 702-228-9066 | |
Sora Song, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3201 S Maryland Pkwy Ste 608, Las Vegas, NV 89109 Phone: 702-457-5437 Fax: 702-464-5801 | |
Dr. Noah Benjamin Kohn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1800 W. Charleston Blvd., Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 888-456-2467 | |
David Blank, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10105 Banburry Cross Dr, Suite 370, Las Vegas, NV 89144 Phone: 702-260-4525 Fax: 702-869-0133 | |
Vicki Hom, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4570 S. Eastern Ave, Suite #21, Las Vegas, NV 89119 Phone: 702-733-6033 Fax: 702-733-6033 | |
Ms. Elsa H Von Schulenburg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4800 Alpine Pl, Suite 10, Las Vegas, NV 89107 Phone: 702-851-3572 Fax: 702-851-3574 | |
Ruben J Acherman, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3131 La Canada St Ste 230, Las Vegas, NV 89169 Phone: 702-732-1290 Fax: 702-732-1385 |